Medtronic (NYSE: MDT) reported Q1 EPS of $1.45, $0.06 better than the analyst estimate of $1.39. Revenue for the quarter came in at $9.8 billion versus the consensus estimate of $9.55 billion.

GUIDANCE:

Medtronic sees FY2027 EPS of $5.94-$6.00, versus the consensus of $5.95.

For earnings history and earnings-related data on Medtronic (MDT) click here.